Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

104 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Biomarkers in obstructive respiratory diseases: an update.
Braido F, Bagnasco D, Scichilone N, Santus P, Solidoro P, Di Marco F, Corsico A, Canonica GW. Braido F, et al. Among authors: bagnasco d. Panminerva Med. 2012 Jun;54(2):119-27. Panminerva Med. 2012. PMID: 22525566 Review.
Sub-lingual administration of a polyvalent mechanical bacterial lysate (PMBL) in patients with moderate, severe, or very severe chronic obstructive pulmonary disease (COPD) according to the GOLD spirometric classification: A multicentre, double-blind, randomised, controlled, phase IV study (AIACE study: Advanced Immunological Approach in COPD Exacerbation).
Braido F, Melioli G, Cazzola M, Fabbri L, Blasi F, Moretta L, Canonica GW; AIACE Study Group. Braido F, et al. Pulm Pharmacol Ther. 2015 Aug;33:75-80. doi: 10.1016/j.pupt.2015.03.006. Epub 2015 May 5. Pulm Pharmacol Ther. 2015. PMID: 25951945 Clinical Trial.
Biosimilars in allergic diseases.
Ferrando M, Bagnasco D, Braido F, Varricchi G, Canonica GW. Ferrando M, et al. Among authors: bagnasco d. Curr Opin Allergy Clin Immunol. 2016 Feb;16(1):68-73. doi: 10.1097/ACI.0000000000000226. Curr Opin Allergy Clin Immunol. 2016. PMID: 26595424 Review.
Update on immunotherapy for the treatment of asthma.
Canonica GW, Bagnasco D, Ferrantino G, Ferrando M, Passalacqua G. Canonica GW, et al. Among authors: bagnasco d. Curr Opin Pulm Med. 2016 Jan;22(1):18-24. doi: 10.1097/MCP.0000000000000227. Curr Opin Pulm Med. 2016. PMID: 26606076 Review.
The safety of monoclonal antibodies in asthma.
Passalacqua G, Matucci A, Vultaggio A, Bagnasco D, Mincarini M, Maggi E, Canonica GW. Passalacqua G, et al. Among authors: bagnasco d. Expert Opin Drug Saf. 2016 Aug;15(8):1087-95. doi: 10.1080/14740338.2016.1186641. Expert Opin Drug Saf. 2016. PMID: 27215447 Review.
The path to personalized medicine in asthma.
Bagnasco D, Ferrando M, Bernardi S, Passalacqua G, Canonica GW. Bagnasco D, et al. Expert Rev Respir Med. 2016 Sep;10(9):957-65. doi: 10.1080/17476348.2016.1205490. Epub 2016 Jul 11. Expert Rev Respir Med. 2016. PMID: 27399975 Review.
104 results